Treatment of primary osteoporosis in men
Andrea Giusti,1 Gerolamo Bianchi2 1Bone Clinic, Department of Gerontology and Musculoskeletal Sciences, Galliera Hospital, 2Department of Rheumatology, La Colletta Hospital, ASL3, Arenzano, Genoa, Italy Abstract: With the aging of the population worldwide, osteoporosis and osteoporotic fra...
Guardado en:
Autores principales: | Giusti A, Bianchi G |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c83cdb2addd7488e92665ccf68c1842a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss
por: Anne-Priscille Trouvin, et al.
Publicado: (2010) -
Osteoporosis in men: epidemiology and treatment with denosumab
por: Sidlauskas KM, et al.
Publicado: (2014) -
Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report
por: Pan WL, et al.
Publicado: (2017) -
Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment
por: Claudia Gagnon, et al.
Publicado: (2008) -
Clinical utility of denosumab for treatment of bone loss in men and women
por: Adler R, et al.
Publicado: (2011)